Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Diurnal Ltd.
DescriptionDry granule formulation of hydrocortisone
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase III
Standard IndicationAdrenal insufficiency
Indication DetailsTreat adrenal insufficiency in children under 6 years of age
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today